glp 1 agonist oral drugs New GLP-1 Guidelines for Type 2 Diabetes in 2025 The Age of Oral GLP-1s

Medi-Cal members will be able to keep their GLP-1 coverage if they can demonstrate it is medically necessary for purposes other than weight loss, the Department of Health Care Services said

Abtahi, S., Howell, E

GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver disease and type 2 diabetes Rachel Fieldhouse, Nature magazine Why Ozempic and Wegovy Might Change Some Peoples Favorite Foods Some users of GLP-1 weight-loss drugs have been reporting strange changes in food preferences, such as a new dislike for meats or fried foods, and scientists are beginning to figure out why Lori Youmshajekian

doi:10.1016/j.neuroscience.2011.02.023 27